<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00997126</url>
  </required_header>
  <id_info>
    <org_study_id>MMRF093030</org_study_id>
    <nct_id>NCT00997126</nct_id>
  </id_info>
  <brief_title>Propofol Versus Alfentanil Versus Nitrous Oxide for Moderate Procedural Sedation</brief_title>
  <official_title>Propofol Versus Alfentanil Versus Nitrous Oxide for Moderate Procedural Sedation in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minneapolis Medical Research Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minneapolis Medical Research Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical trial of propofol and alfentanil as agents for moderated procedural
      sedation in patients undergoing sedation in the emergency department (ED).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This was initially going to be a trial of propofol vs alfentanil vs nitrous oxide, but our
      use of nitrous oxide was discontinued before the trial began and the trial was conducted with
      only two arms
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Sub-clinical Respiratory Depression and Clinical Events Associated With Respiratory Depression During the Sedation Procedure</measure>
    <time_frame>From one minute prior to start of procedure until the patient has returned to baseline mental status after the conclusion of the sedation procedure (~3-60 minutes depending on procedure duration)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Return of Baseline Mental Status From Start of Procedure in Minutes</measure>
    <time_frame>Single time point after completion of sedation procedure, measured from start of procedure until the patient returns to baseline mental status up to 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depth of Sedation Measured Using the OAAS Scale</measure>
    <time_frame>Single measurement during sedation procedure</time_frame>
    <description>Observers Assesment of Alertness Scale, 5 responds normally to voice, 4 lethargic response to voice, 3 responds only to loud voice or light touch, 2 responds only to mild prodding or shaking, 1 responds only to painful stimuli, 0 no response to painful stimuli</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Pain</measure>
    <time_frame>Single measurement immediately after patient returns to baseline mental status after sedation procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Recall of the Procedure</measure>
    <time_frame>Single measurement immediately after patient returns to baseline mental status after sedation procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Sedation</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol 1m g/kg IV followed by 0.5 mg/kg IV prn sedation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alfentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sedation using alfentanil 10 ug/kg followed by 5 ug/kg prn sedation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol 1 mg/kg IV followed by 0.5 mg/kg prn sedation</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alfentanil</intervention_name>
    <description>Alfentanil 10 ug/kg IV followed by 5 ug/kg prn sedation</description>
    <arm_group_label>Alfentanil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults undergoing moderate procedural sedation in the Emergency Department

        Exclusion Criteria:

          -  Age &lt;18 years

          -  Pregnancy

          -  Intoxication

          -  Cannot give informed consent

          -  Allergy to any of the three study medications

          -  ASA physical status score &gt; 2

          -  Patients who require deep procedural sedation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James R Miner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minneapolis Medical Research Foundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hennepin County Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2009</study_first_submitted>
  <study_first_submitted_qc>October 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2009</study_first_posted>
  <results_first_submitted>September 12, 2016</results_first_submitted>
  <results_first_submitted_qc>December 1, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 27, 2017</results_first_posted>
  <last_update_submitted>December 1, 2016</last_update_submitted>
  <last_update_submitted_qc>December 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>propofol</keyword>
  <keyword>alfentanil</keyword>
  <keyword>nitrous oxide</keyword>
  <keyword>moderate procedural sedation</keyword>
  <keyword>Moderate Procedural Sedation in the Emergency Department</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Alfentanil</mesh_term>
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Propofol</title>
          <description>Propofol 1m g/kg IV followed by 0.5 mg/kg IV prn sedation
Propofol: Propofol 1 mg/kg IV followed by 0.5 mg/kg prn sedation</description>
        </group>
        <group group_id="P2">
          <title>Alfentanil</title>
          <description>Sedation using alfentanil 10 ug/kg followed by 5 ug/kg prn sedation
Alfentanil: Alfentanil 10 ug/kg IV followed by 5 ug/kg prn sedation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="52"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Propofol</title>
          <description>Propofol 1m g/kg IV followed by 0.5 mg/kg IV prn sedation
Propofol: Propofol 1 mg/kg IV followed by 0.5 mg/kg prn sedation</description>
        </group>
        <group group_id="B2">
          <title>Alfentanil</title>
          <description>Sedation using alfentanil 10 ug/kg followed by 5 ug/kg prn sedation
Alfentanil: Alfentanil 10 ug/kg IV followed by 5 ug/kg prn sedation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="56"/>
            <count group_id="B2" value="52"/>
            <count group_id="B3" value="108"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36" lower_limit="18" upper_limit="64"/>
                    <measurement group_id="B2" value="32" lower_limit="18" upper_limit="82"/>
                    <measurement group_id="B3" value="34" lower_limit="18" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Sub-clinical Respiratory Depression and Clinical Events Associated With Respiratory Depression During the Sedation Procedure</title>
        <time_frame>From one minute prior to start of procedure until the patient has returned to baseline mental status after the conclusion of the sedation procedure (~3-60 minutes depending on procedure duration)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol</title>
            <description>Propofol 1m g/kg IV followed by 0.5 mg/kg IV prn sedation
Propofol: Propofol 1 mg/kg IV followed by 0.5 mg/kg prn sedation</description>
          </group>
          <group group_id="O2">
            <title>Alfentanil</title>
            <description>Sedation using alfentanil 10 ug/kg followed by 5 ug/kg prn sedation
Alfentanil: Alfentanil 10 ug/kg IV followed by 5 ug/kg prn sedation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Sub-clinical Respiratory Depression and Clinical Events Associated With Respiratory Depression During the Sedation Procedure</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Return of Baseline Mental Status From Start of Procedure in Minutes</title>
        <time_frame>Single time point after completion of sedation procedure, measured from start of procedure until the patient returns to baseline mental status up to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol</title>
            <description>Propofol 1m g/kg IV followed by 0.5 mg/kg IV prn sedation
Propofol: Propofol 1 mg/kg IV followed by 0.5 mg/kg prn sedation</description>
          </group>
          <group group_id="O2">
            <title>Alfentanil</title>
            <description>Sedation using alfentanil 10 ug/kg followed by 5 ug/kg prn sedation
Alfentanil: Alfentanil 10 ug/kg IV followed by 5 ug/kg prn sedation</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Return of Baseline Mental Status From Start of Procedure in Minutes</title>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="9" upper_limit="17"/>
                    <measurement group_id="O2" value="13" lower_limit="10" upper_limit="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depth of Sedation Measured Using the OAAS Scale</title>
        <description>Observers Assesment of Alertness Scale, 5 responds normally to voice, 4 lethargic response to voice, 3 responds only to loud voice or light touch, 2 responds only to mild prodding or shaking, 1 responds only to painful stimuli, 0 no response to painful stimuli</description>
        <time_frame>Single measurement during sedation procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol</title>
            <description>Propofol 1m g/kg IV followed by 0.5 mg/kg IV prn sedation
Propofol: Propofol 1 mg/kg IV followed by 0.5 mg/kg prn sedation</description>
          </group>
          <group group_id="O2">
            <title>Alfentanil</title>
            <description>Sedation using alfentanil 10 ug/kg followed by 5 ug/kg prn sedation
Alfentanil: Alfentanil 10 ug/kg IV followed by 5 ug/kg prn sedation</description>
          </group>
        </group_list>
        <measure>
          <title>Depth of Sedation Measured Using the OAAS Scale</title>
          <description>Observers Assesment of Alertness Scale, 5 responds normally to voice, 4 lethargic response to voice, 3 responds only to loud voice or light touch, 2 responds only to mild prodding or shaking, 1 responds only to painful stimuli, 0 no response to painful stimuli</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O2" value="3" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Pain</title>
        <time_frame>Single measurement immediately after patient returns to baseline mental status after sedation procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol</title>
            <description>Propofol 1m g/kg IV followed by 0.5 mg/kg IV prn sedation
Propofol: Propofol 1 mg/kg IV followed by 0.5 mg/kg prn sedation</description>
          </group>
          <group group_id="O2">
            <title>Alfentanil</title>
            <description>Sedation using alfentanil 10 ug/kg followed by 5 ug/kg prn sedation
Alfentanil: Alfentanil 10 ug/kg IV followed by 5 ug/kg prn sedation</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Pain</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Recall of the Procedure</title>
        <time_frame>Single measurement immediately after patient returns to baseline mental status after sedation procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol</title>
            <description>Propofol 1m g/kg IV followed by 0.5 mg/kg IV prn sedation
Propofol: Propofol 1 mg/kg IV followed by 0.5 mg/kg prn sedation</description>
          </group>
          <group group_id="O2">
            <title>Alfentanil</title>
            <description>Sedation using alfentanil 10 ug/kg followed by 5 ug/kg prn sedation
Alfentanil: Alfentanil 10 ug/kg IV followed by 5 ug/kg prn sedation</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Recall of the Procedure</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.657</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From 1 minute prior to the procedure until the patient returned to baseline mental status</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Propofol</title>
          <description>Propofol 1m g/kg IV followed by 0.5 mg/kg IV prn sedation
Propofol: Propofol 1 mg/kg IV followed by 0.5 mg/kg prn sedation</description>
        </group>
        <group group_id="E2">
          <title>Alfentanil</title>
          <description>Sedation using alfentanil 10 ug/kg followed by 5 ug/kg prn sedation
Alfentanil: Alfentanil 10 ug/kg IV followed by 5 ug/kg prn sedation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="52"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="56"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="52"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>any airway or respiratory adverse event</sub_title>
                <description>interventions during the procedure associated with respiratory depression, or change in ventilation including an oxygen sat &lt;93% or apnea &gt;6 seconds</description>
                <counts group_id="E1" events="30" subjects_affected="25" subjects_at_risk="56"/>
                <counts group_id="E2" events="35" subjects_affected="29" subjects_at_risk="52"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>our capability of administering nitrous oxide was diminished as the trial was started, and the trial was conducted using on the propofol and alfentanil arms.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>James Miner</name_or_title>
      <organization>MinneapolisMRF</organization>
      <phone>6128732493</phone>
      <email>miner015@umn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

